. >> the lineup tonight with me is tim seymour, guy adami, karen finerman and bonawyn eison >> do these names deserve a second look? names straight ahead and in the after hours session and we are having fun later as we he as we talk about companies that should be on your radar. next week is monster reporting >>> hi, carter, who is charting the action >> it was a big week for rates and areas of the market benefit from that. most notably banks and other financials, but lets look at a handful of charts. the first i have is the ten-year yield chart. what you see is that for the first time in almost two years the moving average is flat and on the cusp of turning up. the point of a moving average, when you break above a trend or you can measure it and the automated average is a trend line, the trend is measured by the inflection point we have that by all accounts in ten-year yields. and the second chart is the same circumstance the moving average has been declining for sometime and is now declining and deflecting upward next, same circumstance. do all turns persist could these faith and turn

tim seymour, guy adami, karen finerman, and joe terranova we are looking for gilead to pop on fda approval of remdesivir. and later, mall madness in shares of gas. what the retailer said about the future that sent it flying off the rack an alert on intel. >> i just checked in with c.j. muse, he covers intel. he said it was a disappointing report relative to expectations. said the all important dcg business disappointed. revenue came in at 5.9 billion and they were looking for closer to 6.2 billion they said demanding is holding up, but government not so much he said it is likely to continue because there is too many uncertainties and how much of a competitive risk is amd. and i was e-mailed about gross margin guides. it was 55%, below his call and below what they previously told the street, that 57% was expected next year tomorrow on squawk alley, tune in for that one. jo john forte will be interviewing bob swan >> tim, i know closing bell spoke to stacy last hour they said this is the beginning of the bear thesis why might stacy be wrong or have you changed your mind? >> the manufacturing

tonight's trader line-up, guy adami, tim seymour, karen finerman and dan nathan. and the chart master has the one chart to play as wekick off this fourth quarter. plus, more on today's crude collapse oil falling hard again we will look for any buying opportunities in this beaten-down sector later, a bed bath & beyond stock handing in one of its best days ever one of our traders says it could be headed even higher from here. >>> we start with a developing story out of washington. the next round of coronavirus aid apparently hanging in the balance. let's get right to it with ylan mui. >> reporter: the house has begun debate on democrats' $2.2 trillion relief package with a vote expected later on this evening. five straight days of negotiations between the treasury secretary and the speaker of the house nancy pelosi have failed so far to produce a compromise the white house has propose aes $1.6 trillion bill but those numbers are still far below what democrats are willing to accept. pelosi also pointed to business and child tax credits as another major sticking point

tim seymour, guy adami, karen finerman, and joe terranova we are looking for gilead to pop on fda approvaldness in shares of gas. what the retailer said about the future that sent it flying off

. >> the lineup tonight with me is tim seymour, guy adami, karen finerman and bonawyn eison >> do thesed look? names straight ahead and in the after hours session an

tonight's trader line-up, guy adami, tim seymour, karen finerman and dan nathan. master has the one chart to play as wekick off this fourth quarter. plus, more on today's crude collapse oil falling hard again we will look for any buying opportunities in this beaten-down sector later, a bed